Sirio Pharma Co Ltd
SZSE:300791

Watchlist Manager
Sirio Pharma Co Ltd Logo
Sirio Pharma Co Ltd
SZSE:300791
Watchlist
Price: 25.7 CNY -5.31% Market Closed
Market Cap: 6B CNY
Have any thoughts about
Sirio Pharma Co Ltd?
Write Note

Sirio Pharma Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sirio Pharma Co Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Sirio Pharma Co Ltd
SZSE:300791
Cost of Revenue
-ÂĄ2.5B
CAGR 3-Years
-21%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Hengan International Group Company Ltd
HKEX:1044
Cost of Revenue
-ÂĄ15.2B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-4%
Proya Cosmetics Co Ltd
SSE:603605
Cost of Revenue
-ÂĄ3.3B
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Cost of Revenue
-ÂĄ1.5B
CAGR 3-Years
-31%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
By-health Co Ltd
SZSE:300146
Cost of Revenue
-ÂĄ2.9B
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
G
Giant Biogene Holding Co Ltd
HKEX:2367
Cost of Revenue
-ÂĄ577m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sirio Pharma Co Ltd
Glance View

Market Cap
6.1B CNY
Industry
Consumer products

Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
36.69 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Sirio Pharma Co Ltd's Cost of Revenue?
Cost of Revenue
-2.5B CNY

Based on the financial report for Dec 31, 2023, Sirio Pharma Co Ltd's Cost of Revenue amounts to -2.5B CNY.

What is Sirio Pharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-19%

Over the last year, the Cost of Revenue growth was -44%. The average annual Cost of Revenue growth rates for Sirio Pharma Co Ltd have been -21% over the past three years , -19% over the past five years .

Back to Top